Provided by Tiger Trade Technology Pte. Ltd.

HCW Biologics Inc.

1.60
+0.07004.58%
Post-market: 1.650.0500+3.12%19:52 EDT
Volume:79.96K
Turnover:130.14K
Market Cap:3.58M
PE:-0.06
High:1.73
Open:1.60
Low:1.52
Close:1.53
52wk High:28.14
52wk Low:1.50
Shares:2.24M
Float Shares:2.05M
Volume Ratio:1.51
T/O Rate:3.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-27.1846
EPS(LYR):-63.7804
ROE:-151.36%
ROA:-13.88%
PB:0.48
PE(LYR):-0.03

Loading ...

HCW Biologics Targets IND Filing for Solid-Tumor T-Cell Engager HCW11-018b in 1H 2027

Reuters
·
Yesterday

HCW Biologics Maintains Momentum Toward Completion of Ind Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors

THOMSON REUTERS
·
Yesterday

HCW Biologics - Ind Application on Track to be Filed in 1H 2027

THOMSON REUTERS
·
Yesterday

HCW Biologics (HCWB) Receives a Buy from Maxim Group

TIPRANKS
·
Oct 03

HCW Biologics - Registers Resale of up to 1,807,228 Shares of Common Stock by Selling Stockholder- SEC Filing

THOMSON REUTERS
·
Oct 03

NASDAQ Trade Halt Volatility Trading Pause at 10:04 Am

Reuters
·
Sep 24

HCW Biologics Prices USD 1.5 Million Private Placement at USD 1.6599 Per Unit

Reuters
·
Sep 24

HCW Biologics Announces Pricing of $1.5 Million Private Placement

THOMSON REUTERS
·
Sep 24

HCW Biologics Updates Special Meeting Proxy Materials

TIPRANKS
·
Sep 10

HCW Biologics Signs Exclusive Distribution Deal with Akron Biotech for HCW11-006 Reagent Commercialization

Reuters
·
Sep 08

HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells

THOMSON REUTERS
·
Sep 08

HCW Biologics Announces Special Shareholder Meeting

Reuters
·
Sep 08

HCW Biologics receives patent allowance for alopecia areata drug

TIPRANKS
·
Sep 02

HCW Biologics Wins USPTO Patent Allowance for Hcw9302 Use in Alopecia Areata Treatment

Reuters
·
Sep 02

HCW Biologics Says TGF-Β Trap-IL-15 Fusion Expands CD8+ T, NK Cells in Human Studies

Reuters
·
Aug 25

HCW Biologics files to sell 1.24M shares of common stock for holders

TIPRANKS
·
Aug 21

Cancer Immunotherapy Developer CEL-SCI's Q3 Net Loss Unchanged

Reuters
·
Aug 17

Inflammation Drug Developer HCW Biologics' Q2 Net Loss Widens

Reuters
·
Aug 15

HCW Biologics Q2 EPS $(11.58), Sales $135.568K Up From $6.550K YoY

Benzinga Earnings
·
Aug 15

HCW Biologics Q2 FY26 Net Loss Widens to $5.2 Million; Revenue Rises to $135,568

Reuters
·
Aug 15